Vision & Mission
Board
Founder & Chairmain
Activities
Ongoing Research
Infection Control Guidelines
Scientific Meeting
Scientific Societie
Peer Review Journal
New Papers Reports
IFIC
SeqNet.org
Endorsement
Donations

 

Main Office:

Phone: (54-11) 4854-8329
Cel: (54-9-11) 5691-1775
Fax: (54-11) 4855-2844
victor_rosenthal@inicc.org

 

Research Center:

Phone: (54-11) 4585-1356
Fax: (54-11) 4585-2803
info@inicc.org
 
 PUBLISHED SCIENTIFIC RESEARCH

Should we use closed or open infusion containers for prevention of bloodstream infections? Ann Clin Microbiol Antimicrob. 2010 Feb 2;9:6. - 2010


Rangel-Frausto MS, Higuera-Ramirez F, Martinez-Soto J, Rosenthal VD.

Volver


BACKGROUND: Hospitalized patients in critical care settings are at risk for bloodstream infections (BSI). Most BSIs originate from a central line (CL), and they increase length of stay, cost, and mortality. Open infusion containers may increase the risk of contamination and administration-related (CLAB) because they allow the entry of air into the system, thereby also providing an opportunity for microbial entry. Closed infusion containers were designed to overcome this flaw. However, open infusion containers are still widely used throughout the world.The objective of the study was to determine the effect of switching from open (glass, burettes, and semi-rigid) infusion containers to closed, fully collapsible, plastic infusion containers (Viaflex) on the rate and time to onset of central line-associated bloodstream infections CLABs.


METHODS: An open label, prospective cohort, active healthcare-associated infection surveillance, sequential study was conducted in four ICUs in Mexico. Centers for Disease Control National Nosocomial Infections Surveillance Systems definitions were used to define device-associated infections.


RESULTS: A total of 1,096 adult patients who had a central line in place for >24 hours were enrolled. The CLAB rate was significantly higher during the open versus the closed container period (16.1 versus 3.2 CLAB/1000 central line days; RR = 0.20, 95% CI = 0.11-0.36, P < 0.0001). The probability of developing CLAB remained relatively constant in the closed container period (1.4% Days 2-4 to 0.5% Days 8-10), but increased in the open container period (4.9% Days 2-4 to 5.4% Days 8-10). The chance of acquiring a CLAB was significantly decreased (81%) in the closed container period (Cox proportional hazard ratio 0.19, P < 0.0001). Mortality was statistically significantly lower during the closed versus the open container period (23.4% versus 16.1%; RR = 0.69, 95% CI = 0.54-0.88, P < 0.01).


CONCLUSIONS: Closed infusion containers significantly reduced CLAB rate, the probability of acquiring CLAB, and mortality.


Listado de paises integrantes



Listado de paises integrantes
 Trabajos Cientificos Publicados